In the realm of non-surgical medical treatments, low-level laser therapy (LLLT), also known as photobiomodulation, has emerged as a topic of growing interest and debate. For decades, researchers and clinicians have explored its applications across various disease categories, from skin disorders to neurodegenerative conditions. Yet, inconsistencies in clinical outcomes and a need for deeper mechanistic understanding have kept this therapy in the spotlight of ongoing investigation. In this blog, we’ll dive into the science behind LLLT, its diverse applications, biphasic dose responses, potential side effects, and the future of this promising yet complex treatment modality—all supported by key research findings from leading studies.

What Is Low-Level Laser Therapy (LLLT)?

LLLT refers to the use of low-power lasers (typically in the visible to near-infrared spectral band, 390–1100 nm) that act on biological systems through non-thermal mechanisms. Unlike high-power lasers used for cutting or ablating tissue, LLLT works by triggering photochemical reactions at the cellular level, primarily through the absorption of photons by chromophores (such as cytochrome c oxidase in mitochondria) [3,4]. This absorption initiates a cascade of biological responses, including increased adenosine triphosphate (ATP) production, modulation of reactive oxygen species (ROS), and activation of transcription factors—all of which influence cell proliferation, migration, and repair [4,5].

Notably, LLLT’s effects are not universal; they depend on critical parameters like wavelength, irradiance, fluence (energy density), and treatment duration. As highlighted in Mansouri et al. (2020), these variables must be carefully tailored to the target tissue and condition to achieve therapeutic benefits [1]. Common lasers used in LLLT include HeNe (633 nm), diode lasers (630–980 nm), and ruby lasers (694 nm), each with specific chromophore affinities and tissue penetration capabilities [4].

Key Applications of LLLT Across Medical Fields

Research has identified LLLT’s potential in treating a wide range of conditions, spanning four primary categories outlined in Mansouri et al. (2020): brain-related diseases, skin-related diseases, cancers, and bone-related disorders [1]. Let’s explore these applications in detail, supported by clinical and preclinical evidence:

1. Brain and Neurological Disorders

Transcranial LLLT (tLLT) has shown promise in treating traumatic brain injury (TBI), neurodegenerative diseases, and chronic pain. Huang et al. (2011) demonstrated that tLLT using 810-nm lasers improved neurological outcomes in mice with TBI, with peak benefits observed at specific energy densities [3]. However, the study also emphasized a biphasic response: excessive irradiance (10x the therapeutic dose) eliminated benefits and even worsened outcomes, while repeated daily treatments lost efficacy after 5 days [3]. This underscores the importance of precise dosing in neurological applications.

2. Skin Conditions

LLLT is widely used in dermatology for wound healing, acne, scar reduction, and hair removal. Arjmand et al. (2021) noted that LLLT accelerates wound healing by stimulating fibroblast proliferation and collagen synthesis, while reducing inflammation and edema [2]. For example, Rocha Júnior et al. (2007) (cited in Arjmand et al., 2021) found that LLLT improved human wound healing through both in vitro and in vivo mechanisms [2]. However, as Khalkhal et al. (2020) warned, skin-related side effects—such as hyperpigmentation, hypopigmentation, and paradoxical hypertrichosis (unwanted hair growth)—can occur, especially with improper fluence or patient-specific factors like dark skin or hormonal imbalances [4].

3. Cancer Therapy

While high-power lasers are used for tumor ablation, LLLT’s role in cancer treatment is more nuanced. Mansouri et al. (2020) reviewed studies showing that LLLT can modulate cancer cell metabolism and proliferation, with potential applications in supporting conventional therapies like chemotherapy [1]. For instance, a system biology study by Mansouri et al. (2019) (cited in Mansouri et al., 2020) analyzed LLLT’s effects on squamous cell carcinoma patients, highlighting its potential to alter signaling pathways involved in tumor growth [1]. However, caution is warranted: Mussttaf et al. (2019) noted that LLLT may impact DNA integrity, and its safety in cancer patients requires further validation [5].

4. Bone and Musculoskeletal Disorders

LLLT has been investigated for treating bone fractures, osteoporosis, and tendinopathies. Arjmand et al. (2021) cited a pilot study by Tumilty et al. (2008) showing that LLLT reduced pain in patients with Achilles tendinopathy [2]. In animal models, Seifi et al. (2007) (cited in Mansouri et al., 2020) found that 850-nm and 630-nm lasers influenced orthodontic tooth movement in rabbits, suggesting potential applications in orthopedics and dentistry [1]. The mechanism likely involves enhanced osteoblast activity and reduced inflammation, though optimal wavelengths and treatment regimens remain under study [2].

The Biphasic Dose Response: A Critical Consideration

One of the most intriguing—and challenging—aspects of LLLT is its biphasic dose response, also known as the Arndt-Schulz curve. As Huang et al. (2011) explained, LLLT’s effects follow a U-shaped or inverted U-shaped pattern: low to moderate doses produce beneficial effects, while excessively low or high doses are ineffective or even harmful [3]. For example:

• In vitro studies show that ATP production and mitochondrial membrane potential increase at moderate fluences but decrease at high fluences [3].
• In wound healing, Gal et al. (2009) (cited in Huang et al., 2011) found that 670-nm laser therapy improved tensile strength at specific power densities but had no effect at higher or lower levels [3].
• In TBI treatment, increasing irradiance tenfold eliminated therapeutic benefits and worsened neurological outcomes [3].

This biphasic response explains many inconsistencies in LLLT research and underscores the need for personalized dosing based on the target tissue, condition, and patient characteristics [3,5].

Potential Side Effects and Safety Considerations

While LLLT is generally considered safe, it is not without risks. Khalkhal et al. (2020) conducted a comprehensive review of laser therapy’s side effects, categorizing them by tissue type [4]:

• Epidermal side effects: Bacterial/viral infections, persistent erythema, scarring, and hypertrichosis (more common with CO2, Er:YAG, and pulsed dye lasers) [4].
• Ocular side effects: In diabetic retinopathy patients, laser therapy can cause macular edema, reduced night vision, retinal scarring, and choroidal detachment [4]. Deschler et al. (2014) (cited in Khalkhal et al., 2020) noted that these risks are inherent to retinal photocoagulation, as lasers destroy outer retinal cells to improve oxygenation [4].
• Systemic effects: Intravascular laser blood irradiation may alter metabolomic profiles, including changes in glucose, cholesterol, and hormone levels [4]. In diabetic patients, Kazemi Khoo et al. (2013) (cited in Khalkhal et al., 2020) reported reduced plasma glucose and increased L-arginine levels after treatment [4].

To mitigate these risks, Arjmand et al. (2021) emphasized the importance of: (1) selecting the appropriate laser type and parameters, (2) training clinicians to avoid excessive energy delivery, and (3) informing patients of potential side effects before treatment [2].

The Future of LLLT: What’s Next?

Despite its challenges, LLLT holds immense potential for advancing non-surgical medicine. Researchers agree that future progress will depend on:

1. Mechanistic clarity: Further studies on LLLT’s molecular pathways, such as its effects on DNA repair (Mussttaf et al., 2019) [5] and ROS signaling (Huang et al., 2011) [3].
2. Standardized protocols: Developing evidence-based guidelines for dosing, wavelength selection, and treatment frequency across conditions [1,2].
3. Personalized medicine: Tailoring LLLT to patient-specific factors like skin type, disease severity, and comorbidities [4,5].
4. Combination therapies: Exploring LLLT’s synergy with regenerative medicine, pharmaceuticals, and other non-invasive treatments [2].

As Mansouri et al. (2020) concluded, LLLT’s positive aspects—including its non-invasiveness and broad applicability—outweigh its limitations, but more research is needed to optimize its use [1].

Final Thoughts

Low-level laser therapy is a dynamic and evolving field that bridges photophysics, cell biology, and clinical medicine. Its ability to modulate cellular function without thermal damage makes it a promising option for conditions where conventional treatments fall short. However, success hinges on understanding its biphasic dose response, mitigating side effects, and standardizing protocols. As research continues to unravel LLLT’s mechanisms and expand its applications, it may soon become a staple in dermatology, neurology, orthopedics, and beyond.

If you’re considering LLLT for a specific condition, consult a trained clinician who can assess your eligibility and recommend evidence-based treatment. And stay tuned—this therapy is only beginning to reveal its full potential.

References

• Mansouri V, Arjmand B, Rezaei Tavirani M, et al. Evaluation of Efficacy of Low-Level Laser Therapy. J Lasers Med Sci. 2020 Fall;11(4):369-380. doi:10.34172/jlms.2020.60
• Arjmand B, Khodadost M, Jahani Sherafat S, et al. Low-Level Laser Therapy: Potential and Complications. J Lasers Med Sci. 2021;12:e42. doi:10.34172/jlms.2021.42
• Huang Y-Y, Sharma SK, Carroll J, Hamblin MR. Biphasic dose response in low level light therapy – an update. Dose Response. 2011;9(4):602-618. doi:10.2203/dose-response.11-009.Hamblin
• Khalkhal E, Razzaghi M, Rostami-Nejad M, et al. Evaluation of Laser Effects on the Human Body After Laser Therapy. J Lasers Med Sci. 2020;11(1):91-97. doi:10.15171/jlms.2020.15
• Mussttaf RA, Jenkins DFL, Jha AN. Assessing the impact of low level laser therapy (LLLT) on biological systems: a review. Int J Radiat Biol. 2019 Feb;95(2):120-143. doi:10.1080/09553002.2019.1524944